Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA
mBio. 2021 Jan 5;12(1):e02238-20. doi: 10.1128/mBio.02238-20.
The development of safe and effective vaccines against viruses is central to disease control. With advancements in DNA synthesis technology, the production of synthetic viral genomes has fueled many research efforts that aim to generate attenuated viruses by introducing synonymous mutations. Elucidation of the mechanisms underlying virus attenuation through synonymous mutagenesis is revealing interesting new biology that can be exploited for vaccine development. Here, we review recent advancements in this field of synthetic virology and focus on the molecular mechanisms of attenuation by genetic recoding of viruses. We highlight the action of the zinc finger antiviral protein (ZAP) and RNase L, two proteins involved in the inhibition of viruses enriched for CpG and UpA dinucleotides, that are often the products of virus recoding algorithms. Additionally, we discuss current challenges in the field as well as studies that may illuminate how other host functions, such as translation, are potentially involved in the attenuation of recoded viruses.
针对病毒开发安全有效的疫苗是疾病控制的核心。随着 DNA 合成技术的进步,合成病毒基因组的生产推动了许多旨在通过引入同义突变产生减毒病毒的研究工作。通过同义突变阐明病毒衰减的机制揭示了有趣的新生物学,可用于疫苗开发。在这里,我们回顾了合成病毒学这一领域的最新进展,并重点介绍了通过病毒遗传重编码实现衰减的分子机制。我们强调了锌指抗病毒蛋白 (ZAP) 和 RNase L 的作用,这两种蛋白参与抑制富含 CpG 和 UpA 二核苷酸的病毒,这些二核苷酸通常是病毒重编码算法的产物。此外,我们还讨论了该领域当前面临的挑战以及可能阐明其他宿主功能(如翻译)如何参与重编码病毒衰减的研究。
Front Immunol. 2019-6-4
Proc Natl Acad Sci U S A. 2017-1-17
Nat Microbiol. 2022-10
Adv Sci (Weinh). 2025-1
Mol Syst Biol. 2024-10
Cell Syst. 2020-4-22
Cell Rep. 2020-1-7
Proc Natl Acad Sci U S A. 2019-11-12